Chemical Technology

International Petroleum Corp

October 4, 2022

International Petroleum
International Petroleum Corp. Strongly Positioned to Create Stakeholder Value

Spotlight

Acorda Therapeutics, Inc.

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions.

OTHER WHITEPAPERS
news image

Addressing System Management Challenges in Oil and Gas Operations

whitePaper | July 21, 2022

Oil and gas operations require 24/7/365 monitoring to maintain safety, efficiency, and productivity. Unfortunately, the processes and systems involved

Read More
news image

Expanding the Capabilities of Modern SizeExclusion Chromatography with Advanced Particle and Column Hardware

whitePaper | July 22, 2022

Size-exclusion chromatography (SEC) is one of the most commonly used methods for measuring protein aggregation or protein self-association, because of its precision and ease of use.

Read More
news image

Chemicals supply chain: how to catch up the race!

whitePaper | December 13, 2019

The chemical industry has enjoyed strong and consistent performance over the last decade. The market is now being affected by new challenges, from increased global competition and changing customer requirements to disruptive new technologies while increased demand for sustainability, safety, and efficiency is changing not only the way companies work, but the products they produce.

Read More
news image

Chemical Logistics Digital connections and positive reactions

whitePaper | April 8, 2020

Digitalization opens the door to a new age for the chemical industry. It paves the way for companies in the industry from material suppliers to solution and service providers. It is the driving force behind development that creates a new level of efficiency and transparency for the industry’s sensitive supply chains.

Read More
news image

Specifications Guide European Petrochemicals

whitePaper | September 12, 2022

Assessment Window: Assessments are based on the latest information from the market up to the close of the assessment

Read More
news image

2023 chemical industry outlook

whitePaper | September 22, 2022

As the US chemical industry transforms itself by adjusting portfolios, retooling supply chains, and advancing material innovation, 2023 will set the stage for a reset in terms of materials transformation.

Read More

Spotlight

Acorda Therapeutics, Inc.

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions.

Events